Erratum to: Identification of a restriction point at the M/G1 transition in CHO cells (Cellular and Molecular Life Sciences (CMLS), (2004), 61, 5, (600-609), 10.1007/s00018-003-3360-9);Identification of a restriction point at the M/G1 transition in CHO cells

Cellular and Molecular Life Sciences

Volumn 61, Issue 5, 2004, Pages 600-609

  Hulleman, E ^a,b   Bijvelt, J J M ^a   Verkleij, A J ^a   Verrips, C T ^a   Boonstra, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Apoptosis; Cell cycle; M G1 transition; Restriction point; Signal transduction

Indexed keywords

THYMIDINE; TRITIUM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CHO CELL; IMMUNOFLUORESCENCE; MAMMAL CELL; NONHUMAN; WESTERN BLOTTING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 1642333277     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-017-2548-3     Document Type: Erratum

References (68)

1. Zetterberg A. and Larsson O. (1985) Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 82: 5365-5369
2. Pardee A. B. (1974) A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71: 1286-1290
3. Zetterberg A., Larsson O. and Wiman K. G. (1995) What is the restriction point? Curr. Opin. Cell Biol. 7: 835-842
4. Blagosklonny M. V. and Pardee A. B. (2002) The restriction point of the cell cycle. Cell Cycle 1: 103-110
5. Jones S. M. and Kazlauskas A. (2003) Progression from G0 through G1 and into S on two waves of growth factor driven signalling. In: G1 Phase Progression, pp. 187-204, Boonstra J. (ed.), Landes Biosciences, Georgetown
6. Boonstra J. (2003) Progression through the G1 phase of the on-going cell cycle. J. Cell Biochem. 90: 244-252
7. Roovers K. and Assoian R. K. (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22: 818-826
8. Schaeffer H. J. and Weber M. J. ( 1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19: 2435-2444
9. Widmann C., Gibson S., Jarpe M. B. and Johnson G. L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79: 143-180
10. Wilkinson M. G. and Millar J. B. A. (2000) Control of the eukaryotic cell cycle by MAP kinase signalling pathways. FASEB J. 14: 2147-2157
11. Johnson G. L. and Lapadat R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912
12. Chen R. H., Sarnecki C. and Blenis J. (1992) Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol. Cell. Biol. 12: 915-927
13. Gonzalez F. A., Seth A., Raden D. L., Bowman D. S., Fay F. S. and Davis R. J. (1993) Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J. Cell Biol. 122: 1089-1101
14. mapkk) in fibroblasts. J. Cell Biol. 122: 1079-1088
15. Cyert M. S. (2001) Regulation of nuclear localization during signalling. J. Biol. Chem. 276: 20805-20808
16. Horgan A. M. and Stork P. J. (2003) Examining the mechanism of Erk nuclear translocation using green fluorescent protein. Exp. Cell Res. 285: 208-220
17. Pouyssegur J. and Lenormand P. (2003) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur. J. Biochem. 270: 3291-3299
18. Chuang C.-F. and Ng S.-Y. (1994) Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors. FEBS Lett. 346: 229-234
19. Gille H., Kortenjann M., Thomae O., Moomaw C. Slaughter C., Cobb M. H. et al. (1995) ERK phosphorylation potentates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14: 951-962
20. Treisman R. (1996) Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8: 205-215
21. Hazzalinn C. A. and Mahadevan L. C. (2002) MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3: 30-40
22. Albanese C., Johnson J., Watanabe G., Eklund N., Vu D., Arnold A. et al. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597
23. MAPK pathway. J. Biol. Chem. 271: 20608-20616
24. Aktas H., Cai H. and Cooper G. M. (1997) Ras links growth factor signalling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27 KIP1. Mol. Cell. Biol. 17: 3850-3857
25. Weber J. D., Raben D. M., Phillips P. J. and Baldassare J. (1997) Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 326: 61-68
26. Sears R. C. and Nevins J. R. (2002) Signaling networks that link cell proliferation and cell fate. J. Biol. Chem. 277: 11617-11620
27. KIP1 regulated by mitogen-activated protein kinase kinase (MEK). Proc. Natl. Acad. Sci. USA 95: 1091-1096
28. mapk isoforms in the G1 phase and their inactivation at the G1/S transition. J. Cell. Physiol. 163: 577-588
29. Lents N. H., Keenan S. M., Bellone C. and Baldassare J. J. (2002) Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear targeted CDK2. J. Biol. Chem. 277: 47469-47475
30. kip1 degradation and anchorage independence by Ras through the MAP kinase signalling pathway. Oncogene 15: 629-637
31. Takuwa N. and Takuwa Y. (1997) Ras activity late in G1 phase is required for p27kip1 downregulation, passage through the restriction point and entry into S phase in growth factor stimulated NIH 3T3 fibroblasts. Mol. Cell Biol. 17: 5348-5358
32. MAPK during the ongoing cell cycle. J. Cell. Physiol. 180: 325-333
33. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90: 8319-8323
34. Brondello J. M., McKenzie F. R., Sun H., Tonks N. K. and Pouysségur J. (1995) Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10: 1895-1904
35. Squires M. S., Nixon P. M. and Cook S. J. (2002) Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/ 2 but not ERK5/BMK1. Biochem. J. 366: 673-680
36. Jones S. M., Klinghoffer R., Prestwich G. D., Toker A. and Kazlauskas A. (1999) PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr Biol. 9: 512-521
37. Kandel E. S. and Hay N. (1999) The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253: 210-229
38. Marshall C. (1999) How do small GTPase signal transduction pathways regulate cell cycle entry? Curr. Opin. Cell Biol. 11: 732-736
39. Cantrell D. A. (2001) Phosphoinositide 3-kinase signaling pathways. J. Cell Sci. 114: 1439-1445
40. Liang J., Zubovitz J., Petrocelli T., Kotchetkov R., Connor M., K., Han K. et al. (2002) PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8: 1153-1160
41. Bush H. and Shodell M. (1976) Cell cycle changes in transformed cells growing under serum-free conditions. J. Cell. Physiol. 90: 573-583
42. Campisi J., Morreo G. and Pardee A. B. (1984) Kinetics of G1 transit following brief starvation for serum factors. Exp. Cell Res. 152: 459-466
43. Pardee A. B. (1989) G1 events and the regulation of cell proliferation. Science 246: 603-608
44. + transport and electrical membrane properties during the cell cycle. J. Cell. Physiol. 107: 75-83
45. O'Keefe E. J. and Pledger W. J. (1983) A model of cell cycle control: sequential events regulated by growth factors. Mol. Cell. Endocrinol. 31: 167-186
46. Hulleman E., Bijvelt J. J. M., Verkleij A. J., Verrips C. T. and Boonstra J. (1999) Integrin signaling at the M/G1 transition induces expression of cyclin E. Exp. Cell Res. 253: 422-431
47. Sherr C. J. (1993) Mammalian G1 cyclins. Cell 73: 1059-1065
48. Rivard N., L'Allemain G., Bartek J. and Pouysségur J. (1996) Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271: 18337-18341
49. Amstad P. A., Yu G., Johnson G. L., Lee B. W., Dhawan S. and Phelps D. J. (2001) Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors. Biotechniques 31: 608-610
50. Tachibana M. and Murai M. (1998) G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review. Cytokines Cell Mol. Ther. 4: 113-120
51. Rizzino A., Kuszynski C., Ruff E. and Tiesman J. (1988) Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev. Biol. 129: 61-71
52. Wright J. A. and Huang A. (1996) Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF. Histol. Histopathol. 11: 521-236
53. Zoelen E. J. van, Koorneef I., Holthuis J. C., Ward-van Oostwaard T. M., Feijen A., Poorter T. L. de et al. (1989) Production of insulin-like growth factors, platelet-derived growth factor, and transforming growth factors and their role in the density-dependent growth regulation of a differentiated embryonal carcinoma cell line. Endocrinology 124: 2029-2041
54. Zoelen E. J. van, Ward-van Oostwaard T. M., Nieuwland R., Burg B. van der, Eijnden-van Raaij A. J. van den, Mummery C. L. et al. (1989) Identification and characterization of polypeptide growth factors secreted by murine embryonal carcinoma cells. Dev. Biol. 133: 272-283
55. Heldin C. H. and Westermark B. (1987) PDGF-like growth factors in autocrine stimulation of growth. J. Cell Physiol. Suppl. 5: 31-34
56. Rosen N., Yee D., Lippman M. E., Paik S. and Cullen K. J. (1991) Insulin-like growth factors in human breast cancer. Breast Cancer Res. Treat. 18: S55-S62
57. Onoda N., Ohmura E., Tsushima E., Ohba Y., Emoto N., Isozaki O. et al. (1992) Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line. Eur. J. Cancer 28A: 1904-1909
58. Gurley L. R., Jandacek A. L., Valdez J. F., Sebring R. J., D'Anna J. A. and Puck T. (1998) T. Br-cAMP induction of apoptosis in synchronized CHO cells. Somat. Cell Mol. Genet. 24: 173-190
59. Boonstra J., Mummery C. L., Feyen A., Hoog W. J. de, Saag P. T. van der and Laat S. W. de (1987) Epidermal growth factor receptor expression during morphological differentiation of pheochromocytoma cells, induced by nerve growth factor or dibutyryl cyclic AMP. J. Cell. Physiol. 131: 409-417
60. Rydel R. E. and Greene L. A. (1988) cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc. Natl. Acad. Sci. USA 85: 1257-1261
61. Taylor M. and Reh T. A. (1990) Induction of differentiation of rat retinal, germinal, neuroepithelial cells by dbcAMP. J. Neurobiol. 21: 470-481
62. Ho P. L. and Raw I. (1992) Cyclic AMP potentiates bFGF-induced neurite outgrowth in PC12 cells. J. Cell. Physiol. 150: 647-656
63. Erhardt J. A. and Pittman R. N. (1998) Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J. Biol. Chem. 273: 23517-23523
64. Tian J. Q. and Quaroni A. (1999) Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation. Am. J. Physiol. 276: C1245-C1258
65. WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56: 31-35
66. cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18: 3085-3097
67. Peter M., Gartner A., Horecka J., Ammerer G. and Herskowitz I. (1993) FAR1 links the signal transduction pathway to the cell cycle machinery in yeast. Cell 73: 747-760
68. Tyers M. and Futcher B. (1993) Far1 and Fus3 link the mating pheromone signal transduction pathway to three G1-phase cdc28 complexes. Mol. Cell. Biol. 13: 5659-5669